Methodist Dallas Medical Center earns 3 Joint Commission certifications for pancreatic care

Methodist Dallas Medical Center received The Joint Commission's Gold Seal of Approval for Disease-Specific Certification in three categories: pancreatitis, pancreatic surgery and pancreatic cancer.

The two-year certification recognizes "an organization's commitment to providing safe and effective patient care." An on-site review determined that Methodist Dallas was compliant with national standards, used evidence-based clinical practice guidelines and had established organized performance measurement and improvement activities in the three categories.

"Methodist Dallas has thoroughly demonstrated a high level of care for patients with pancreas disease," said Patrick Phelan, executive director of hospital business development at The Joint Commission. "We commend Methodist Dallas for being a leader in pancreas care, potentially providing a higher standard of service for patients suffering from pancreas disease in its community."

More articles on healthcare quality:
2 more infant deaths reported amid bacterial outbreak at New Jersey NICU
Top-ranked hospitals demonstrate worse readmission rates for heart failure, study finds
5 top healthcare performers honored at Press Ganey Florida conference

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers